Alpha Tau Medical【DRTS】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

3.10

買値

3.00

売値

4.94

出来高

0.00 日の範囲 0.00

1.75 52 週間の範囲 3.40

時価総額

215.979M

前日終値

3.10

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

35,619

発行済株式数

69,670,612

配当利回り

PER

-7.41

1 株当たり利益 (EPS)

-0.42

歳入

純利益

-29.16M

Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University. Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University.

セクター

Surgical,med Instr,apparatus

業界

Surgical,med Instr,apparatus

ウェブサイト

www.alphatau.com

本社

Jerusalem, Jerusalem, Isr

設立

Alpha Tau Medical Ltd is listed in the Surgical,med Instr,apparatus sector of the ナスダック市場 with ticker DRTS. The last closing price for Alpha Tau Medical was US$3.10. Over the last year, Alpha Tau Medical shares have traded in a share price range of US$ 1.75 to US$ 3.40.

Alpha Tau Medical currently has 69,670,612 shares in issue. The market capitalisation of Alpha Tau Medical is US$215.98 million. Alpha Tau Medical has a price to earnings ratio (PE ratio) of -7.41.

Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day

JERUSALEM, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor

JERUSALEM, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW), ("Alpha Tau" or the "Company"), the developer of the innovative alpha-radiation cancer therapy Alpha...

Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference

JERUSALEM, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors Symposium

JERUSALEM, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update

- Alpha DaRT® accepted into the prestigious Total Product Life Cycle Advisory Program (TAP) of the FDA, to accelerate market access to the Alpha DaRT® for patients with recurrent glioblastoma...

Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare Conference

JERUSALEM, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme

JERUSALEM, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-emitters cancer therapy Alpha...

Alpha Tau Treats First Patient with Recurrent Lung Cancer

JERUSALEM, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC

JERUSALEM, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.085	2.8192371476	3.015	3.2	3	43250	3.13640826	CS
4	0.76	32.4786324786	2.34	3.2	2.34	62701	2.93864739	CS
12	0.8	34.7826086957	2.3	3.2	2.11	35619	2.6482372	CS
26	0.84	37.1681415929	2.26	3.2	1.75	33720	2.4301471	CS
52	0.1	3.33333333333	3	3.4	1.75	34426	2.62340574	CS
156	-8.45	-73.1601731602	11.55	20.65	1.75	93526	8.84903502	CS
260	-8.45	-73.1601731602	11.55	20.65	1.75	93526	8.84903502	CS

DRTS - Frequently Asked Questions (FAQ)

What is the current Alpha Tau Medical share price?

The current share price of Alpha Tau Medical is US$ 3.10

How many Alpha Tau Medical shares are in issue?

Alpha Tau Medical has 69,670,612 shares in issue

What is the market cap of Alpha Tau Medical?

The market capitalisation of Alpha Tau Medical is USD 215.98M

What is the 1 year trading range for Alpha Tau Medical share price?

Alpha Tau Medical has traded in the range of US$ 1.75 to US$ 3.40 during the past year

What is the PE ratio of Alpha Tau Medical?

The price to earnings ratio of Alpha Tau Medical is -7.41

What is the reporting currency for Alpha Tau Medical?

Alpha Tau Medical reports financial results in USD

What is the latest annual profit for Alpha Tau Medical?

The latest annual profit of Alpha Tau Medical is USD -29.16M

What is the registered address of Alpha Tau Medical?

The registered address for Alpha Tau Medical is KIRYAT HAMADA ST. 5, JERUSALEM, JERUSALEM, 9777605

What is the Alpha Tau Medical website address?

The website address for Alpha Tau Medical is www.alphatau.com

Which industry sector does Alpha Tau Medical operate in?

Alpha Tau Medical operates in the SURGICAL,MED INSTR,APPARATUS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
PHIOPhio Pharmaceuticals Corporation	US$ 4.57 (159.66%)	1.5M
EDBLEdible Garden AG Inc	US$ 0.4069 (71.18%)	6.61M
ABATAmerican Battery Technology Company	US$ 1.71 (50.00%)	1.47M
RUMRumble Inc	US$ 10.13 (40.89%)	315.33k
LAESSEALSQ Corporation	US$ 3.74 (36.00%)	3.76M
ONFOOnfolio Holdings Inc	US$ 1.17 (-26.88%)	2.5k
HSDTHelius Medical Technologies Inc	US$ 0.6985 (-23.24%)	87.2k
NVNINVNI Group Ltd	US$ 6.86 (-20.05%)	71.81k
CNTMConnectM Technology Solutions Inc	US$ 0.832 (-20.00%)	2.2k
PBMPsyence Biomedical Ltd	US$ 2.55 (-19.81%)	17.8k
EDBLEdible Garden AG Inc	US$ 0.4069 (71.18%)	6.61M
LAESSEALSQ Corporation	US$ 3.74 (36.00%)	3.76M
BNRGBrenmiller Energy Ltd	US$ 1.01 (34.08%)	1.68M
PHIOPhio Pharmaceuticals Corporation	US$ 4.57 (159.66%)	1.5M
ABATAmerican Battery Technology Company	US$ 1.71 (50.00%)	1.47M